The University of Glasgow uses cookies for analytics. Find out more about our Privacy policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.
Analytical cookies help us improve our website. We use Google Analytics. All data is anonymised.
Clarity helps us to understand our users’ behaviour by visually representing their clicks, taps and scrolling. All data is anonymised.
email:
Bernadette.White@glasgow.ac.uk
pronouns:
She/her/hers
Jatkowska, A., White, B., Gkikas, K. , Seenan, J. P. , MacDonald, J. and Gerasimidis, K. (2024) Partial enteral nutrition in the management of Crohn’s disease: a systematic review and meta-analysis. Journal of Crohn’s and Colitis, (doi: 10.1093/ecco-jcc/jjae177) (Accepted for Publication)
White, B., Curle, J., Gervais, L., Wands, D., Nichols, B., Hansen, R., Russell, R. K., Gerasimidis, K. and Milling, S. (2024) Exclusive enteral nutrition impacts peripheral blood mononuclear cell profile of children with Crohn’s disease. Journal of Pediatric Gastroenterology and Nutrition, 79(1), pp. 148-153. (doi: 10.1002/jpn3.12258) (PMID:38779951)
Gkikas, K. , Svolos, V., White, B. and Gerasimidis, K. (2024) An update on dietary therapies in paediatric Crohn’s disease. Current Opinion in Clinical Nutrition and Metabolic Care, 27(3), pp. 304-312. (doi: 10.1097/MCO.0000000000001024) (PMID:38456807)
Jatkowska, A., White, B., Jaskolski, P., Nichols, B., Brownson, E., Clowe, J., Seenan, J. P. , Gerasimidis, K. and Macdonald, J. (2024) Perceptions towards established and novel dietary therapies for Crohn’s disease management among adult patients: results from a questionnaire survey. Crohn's and Colitis 360, 6(1), otae008. (doi: 10.1093/crocol/otae008) (PMID:38464347) (PMCID:PMC10924435)
Jatkowska, A. et al. (2023) Development and validation of the Glasgow Exclusive Enteral Nutrition Index of Compliance. Journal of Crohn's and Colitis, 17(9), pp. 1426-1435. (doi: 10.1093/ecco-jcc/jjad063) (PMID:37004165) (PMCID:PMC10588781)
Brownson, E., Saunders, J., Jatkowska, A., White, B., Gerasimidis, K. , Seenan, J. P. and Macdonald, J. (2023) Micronutrient status and prediction of disease outcome in adults with inflammatory bowel disease receiving biologic therapy. Inflammatory Bowel Diseases, (doi: 10.1093/ibd/izad174) (PMID:37611079) (Early Online Publication)
Jatkowska, A., White, B., Gkikas, K. , Seenan, J. P. , MacDonald, J. and Gerasimidis, K. (2024) Partial enteral nutrition in the management of Crohn’s disease: a systematic review and meta-analysis. Journal of Crohn’s and Colitis, (doi: 10.1093/ecco-jcc/jjae177) (Accepted for Publication)
White, B., Curle, J., Gervais, L., Wands, D., Nichols, B., Hansen, R., Russell, R. K., Gerasimidis, K. and Milling, S. (2024) Exclusive enteral nutrition impacts peripheral blood mononuclear cell profile of children with Crohn’s disease. Journal of Pediatric Gastroenterology and Nutrition, 79(1), pp. 148-153. (doi: 10.1002/jpn3.12258) (PMID:38779951)
Gkikas, K. , Svolos, V., White, B. and Gerasimidis, K. (2024) An update on dietary therapies in paediatric Crohn’s disease. Current Opinion in Clinical Nutrition and Metabolic Care, 27(3), pp. 304-312. (doi: 10.1097/MCO.0000000000001024) (PMID:38456807)
Jatkowska, A., White, B., Jaskolski, P., Nichols, B., Brownson, E., Clowe, J., Seenan, J. P. , Gerasimidis, K. and Macdonald, J. (2024) Perceptions towards established and novel dietary therapies for Crohn’s disease management among adult patients: results from a questionnaire survey. Crohn's and Colitis 360, 6(1), otae008. (doi: 10.1093/crocol/otae008) (PMID:38464347) (PMCID:PMC10924435)
Jatkowska, A. et al. (2023) Development and validation of the Glasgow Exclusive Enteral Nutrition Index of Compliance. Journal of Crohn's and Colitis, 17(9), pp. 1426-1435. (doi: 10.1093/ecco-jcc/jjad063) (PMID:37004165) (PMCID:PMC10588781)
Brownson, E., Saunders, J., Jatkowska, A., White, B., Gerasimidis, K. , Seenan, J. P. and Macdonald, J. (2023) Micronutrient status and prediction of disease outcome in adults with inflammatory bowel disease receiving biologic therapy. Inflammatory Bowel Diseases, (doi: 10.1093/ibd/izad174) (PMID:37611079) (Early Online Publication)